725
Participants
Start Date
December 31, 2008
Primary Completion Date
May 31, 2009
Study Completion Date
May 31, 2009
AZD7325
2 tablets taken twice a day for 28 days
AZD7325
2 tablets taken twice a day for 28 days
AZD7325
2 tablets taken twice a day for 28 days
Placebo
2 tablets taken twice a day for 28 days
Research Site, Birmingham
Research Site, Tucson
Research Site, Arcadia
Research Site, Beverly Hills
Research Site, Cerritos
Research Site, Chino
Research Site, Encino
Research Site, Los Alamitos
Research Site, Novato
Research Site, Oceanside
Research Site, San Diego
Research Site, Norwich
Research Site, Fort Myers
Research Site, Miami
Research Site, Pembroke Pines
Research Site, Saint Petersberg
Research Site, Tampa
Research Site, Winter Park
Research Site, Atlanta
Research Site, Marietta
Research Site, Smyrna
Research Site, Libertyville
Research Site, Park Ridge
Research Site, Indianapolis
Research Site, Overland Park
Research Site, Baltimore
Research Site, Boston
Research Site, Cambridge
Research Site, St Louis
Research Site, Clementon
Research Site, Fresh Meadows
Research Site, Mount Kisco
Research Site, New York
Research Site, Rochester
Research Site, Raleigh
Research Site, Winston-Salem
Research Site, Bismarck
Research Site, Beechwood
Research Site, Cincinnati
Research Site, Middleburg Heights
Research Site, Oklahoma City
Research Site, Portland
Research Site, Jenkintown
Research Site, Norristown
Research Site, Memphis
Research Site, Friendswood
Research Site, San Antonio
Research Site, Salt Lake City
Research Site, Woodstock
Research Site, Herndon
Research Site, Spokane
Research Site, Middleton
Lead Sponsor
AstraZeneca
INDUSTRY